- Leukaemia drug nilotinib helped advanced Parkinson's disease patients
- Scientists said those given it for a research study had 'come back to life'
- One wheelchair-bound patient able to walk again, others regained speech
- Researchers now hope ‘life-changing’ drug will help those with Alzheimer's
By FIONA MACRAE SCIENCE CORRESPONDENT FOR THE DAILY MAIL
19 October 2015
Patients with advanced Parkinson’s disease have ‘come back to life’ after being given a cancer drug, said scientists.
In dramatic scenes reminiscent of the Robin Williams film Awakenings, in which a drug was used to awaken catatonic patients, one wheelchair-bound patient was able to walk again.
Others regained the ability to speak or were able to enjoy pleasures such as reading a book once more after taking the drug during a study.
Breakthrough: Scientists say patients with advanced Parkinson’s disease have ‘come back to life’ after being given the cancer drug nilotinib, which is used to treat leukaemia (file photo)
Researchers now hope the ‘life-changing’ drug – a leukaemia treatment called nilotinib – will also work for those with brain conditions such as Alzheimer’s.
The fact the drug has already gone through extensive testing in cancer patients should speed up the approval process for its use treating other conditions whether the results are too good to be true.
More than 125,000 Britons have Parkinson’s, in which the death of the brain cells that produce a chemical called dopamine leads to tremors, stiffness and a gradual slowing of the body.
There is no cure and existing drugs can only provide temporary relief. In contrast, it is thought nilotinib spares the key brain cells from death.
In dramatic scenes reminiscent of the Robin Williams film Awakenings (pictured), in which a drug was used to awaken catatonic patients, one wheelchair-bound patient was able to walk again
The team from Georgetown University in Washington DC gave nilotinib to 12 men and women who had Parkinson’s disease or a similar condition called dementia with Lewy bodies.
The daily dose of the drug for six months had dramatic effects, with some of their worst symptoms being reversed, the Society for Neuroscience’s annual conference heard.
Three patients regained the ability to talk, one was able to walk again and another could feed herself once more.
One patient, retired lecturer Alan Hoffman, said: ‘Before nilotinib, I did almost nothing around the house. Now, I empty the garbage, unload the dishwasher ... I read a book for the first time in a couple of years. My wife says it is life-changing.’
Lead author Dr Charbel Moussa said: ‘We’ve seen patients at end stages of the disease coming back to life.
'We had people as stiff as a board at the start of the study who were walking around, sitting down and bending their legs by the end.’
It is thought nilotinib clears away toxic proteins that accumulate in the brain cells of Parkinson’s patients, so freeing them to make dopamine.
Researcher Dr Fernando Pagan said the drug seemed to be the first to reverse some of the symptoms – but that larger studies were needed to determine its true impact.
Parkinson’s UK has cautioned that the study’s failure to include untreated patients made it impossible to say how well the drug had really worked, warning that ‘just someone’s belief that they are taking a new drug could produce these results’.
Professor Carl Clarke, a neurologist at Birmingham University, added: ‘It seems too good to be true. I dearly hope I am wrong.’
Further trials are now planned.
Read more: http://www.dailymail.co.uk/health/article-3278525/Parkinson-s-victims-brought-life-cancer-drug.html#ixzz3p40W9KQs
Follow us: @MailOnline on Twitter | DailyMail on Facebook
http://health.einnews.com/article/292336681/zOsnByhc8xBFd15N
No comments:
Post a Comment